Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
Cross Creek Advisors
Salt Lake CitySeries B–Late Stage
20 people
Knox Lane
San FranciscoGrowth
41 people
OSAKA University Venture Capital
OsakaPre-Seed–Growth
20 people
Afreximbank
CairoGrowth
46 people
Canadian Business Growth Fund
TorontoGrowth$3.6M – $14.6M
30 people
Helios Digital Ventures
LondonGrowth
29 people
Avoro Capital Advisors
New YorkSeries A–Late Stage
22 people
JAZZ Venture Partners
San FranciscoSeed–Growth$100K – $20M
16 people
Camden Partners
Owings MillsGrowth
14 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
InTandem Capital Partners
New YorkGrowth$5M
37 people
Keio Innovation Initiative
TokyoSeed–Growth
22 people
IDC Ventures
MiamiPre-Seed–Growth
42 people
Decheng Capital
Menlo ParkSeed–Growth
14 people
iGlobe Partners
SingaporeSeed–Growth$600K – $6M
23 people
Rho Ventures
New YorkPre-Seed–Growth$2M – $15M
11 people
Escalate Capital Partners
AustinGrowth–Late Stage
9 people
LIONHEART VENTURES
San FranciscoSeed–Growth
36 people
Oxford Finance LLC
AlexandriaGrowth
42 people
VantagePoint Capital Partners
Silicon ValleySeed–Growth$2M – $100M
18 people
Noro-Moseley Partners
AtlantaSeries A–Growth$5M – $20M
13 people
North Castle Partners
New YorkGrowth
27 people
Boathouse Capital
BerwynGrowth–Late Stage$5M – $50M
17 people
Calera Capital
BostonGrowth$50M – $250M
37 people
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.











































































































